{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:52:19Z","timestamp":1792857139386,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.nucmedbio.2007.05.002","type":"journal-article","created":{"date-parts":[[2007,8,18]],"date-time":"2007-08-18T07:16:56Z","timestamp":1187421416000},"page":"633-641","source":"Crossref","is-referenced-by-count":57,"title":["Renal uptake and retention of radiolabeled somatostatin, bombesin, neurotensin, minigastrin and CCK analogues: species and gender differences"],"prefix":"10.1016","volume":"34","author":[{"given":"Marleen","family":"Melis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric P.","family":"Krenning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bert F.","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"de Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar","family":"Rolleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2007.05.002_bib1","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1196\/annals.1294.026","article-title":"Peptide receptor radionuclide therapy","volume":"1014","author":"Krenning","year":"2004","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"10.1016\/j.nucmedbio.2007.05.002_bib2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1385\/ENDO:20:3:307","article-title":"Octreoscan radioreceptor imaging","volume":"20","author":"van der Lely","year":"2003","journal-title":"Endocrine"},{"issue":"8","key":"10.1016\/j.nucmedbio.2007.05.002_bib3","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/BF00181765","article-title":"Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients","volume":"20","author":"Krenning","year":"1993","journal-title":"Eur J Nucl Med"},{"issue":"Suppl 1","key":"10.1016\/j.nucmedbio.2007.05.002_bib4","first-page":"62S","article-title":"Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs","volume":"46","author":"Kwekkeboom","year":"2005","journal-title":"J Nucl Med"},{"issue":"Suppl 1","key":"10.1016\/j.nucmedbio.2007.05.002_bib5","first-page":"67S","article-title":"Candidates for peptide receptor radiotherapy today and in the future","volume":"46","author":"Reubi","year":"2005","journal-title":"J Nucl Med"},{"issue":"12","key":"10.1016\/j.nucmedbio.2007.05.002_bib6","first-page":"1904","article-title":"Receptor-mediated tumor targeting with radiolabeled peptides: there is more to it than somatostatin analogs","volume":"47","author":"Mariani","year":"2006","journal-title":"J Nucl Med"},{"issue":"12","key":"10.1016\/j.nucmedbio.2007.05.002_bib7","first-page":"1650","article-title":"Preclinical comparison of (111)In-labeled DTPA- or DOTA-bombesin analogs for receptor-targeted scintigraphy and radionuclide therapy","volume":"43","author":"Breeman","year":"2002","journal-title":"J Nucl Med"},{"issue":"6","key":"10.1016\/j.nucmedbio.2007.05.002_bib8","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1021\/bc0498267","article-title":"A new high affinity technetium analogue of bombesin containing DTPA as a pharmacokinetic modifier","volume":"15","author":"Lin","year":"2004","journal-title":"Bioconjug Chem"},{"issue":"2","key":"10.1016\/j.nucmedbio.2007.05.002_bib9","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00259-002-1040-x","article-title":"[99mTc]Demobesin 1, a novel potent bombesin analogue for GRP receptor-targeted tumour imaging","volume":"30","author":"Nock","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"18","key":"10.1016\/j.nucmedbio.2007.05.002_bib10","doi-asserted-by":"crossref","first-page":"6707","DOI":"10.1158\/0008-5472.CAN-03-3845","article-title":"Synthesis and evaluation of bombesin derivatives on the basis of pan-bombesin peptides labeled with indium-111, lutetium-177, and yttrium-90 for targeting bombesin receptor-expressing tumors","volume":"64","author":"Zhang","year":"2004","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.nucmedbio.2007.05.002_bib11","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/bip.10356","article-title":"Cholecystokinin-B (CCK-B)\/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies","volume":"66","author":"Behe","year":"2002","journal-title":"Biopolymers"},{"issue":"8","key":"10.1016\/j.nucmedbio.2007.05.002_bib12","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1007\/s00259-003-1178-1","article-title":"Improved kinetic stability of DTPA-dGlu as compared with conventional monofunctional DTPA in chelating indium and yttrium: preclinical and initial clinical evaluation of radiometal labelled minigastrin derivatives","volume":"30","author":"Behe","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1016\/j.nucmedbio.2007.05.002_bib13","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00259-003-1184-3","article-title":"Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting","volume":"30","author":"Reubi","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"10.1016\/j.nucmedbio.2007.05.002_bib14","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1136\/gut.42.4.546","article-title":"Neurotensin receptors: a new marker for human ductal pancreatic adenocarcinoma","volume":"42","author":"Reubi","year":"1998","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.nucmedbio.2007.05.002_bib15","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1007\/s00259-003-1189-y","article-title":"Stabilised 111In-labelled DTPA- and DOTA-conjugated neurotensin analogues for imaging and therapy of exocrine pancreatic cancer","volume":"30","author":"de Visser","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1016\/j.nucmedbio.2007.05.002_bib16","first-page":"652","article-title":"Somatostatin receptor scintigraphy with indium-111-DTPA-d-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide","volume":"33","author":"Krenning","year":"1992","journal-title":"J Nucl Med"},{"issue":"7","key":"10.1016\/j.nucmedbio.2007.05.002_bib17","first-page":"1168","article-title":"Inhomogeneous localization of radioactivity in the human kidney after injection of [(111)In-DTPA]octreotide","volume":"45","author":"De Jong","year":"2004","journal-title":"J Nucl Med"},{"issue":"10","key":"10.1016\/j.nucmedbio.2007.05.002_bib18","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1007\/s00259-005-1793-0","article-title":"Localisation and mechanism of renal retention of radiolabelled somatostatin analogues","volume":"32","author":"Melis","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"10.1016\/j.nucmedbio.2007.05.002_bib19","first-page":"1696","article-title":"Megalin is essential for renal proximal tubule reabsorption of (111)In-DTPA-octreotide","volume":"46","author":"de Jong","year":"2005","journal-title":"J Nucl Med"},{"issue":"24","key":"10.1016\/j.nucmedbio.2007.05.002_bib20","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.2174\/1381612043383502","article-title":"Development and clinical application of peptide-based radiopharmaceuticals","volume":"10","author":"Gotthardt","year":"2004","journal-title":"Curr Pharm Des"},{"issue":"22","key":"10.1016\/j.nucmedbio.2007.05.002_bib21","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/0024-3205(91)90053-E","article-title":"In vivo application of [111In-DTPA-d-Phe1]-octreotide for detection of somatostatin receptor-positive tumors in rats","volume":"49","author":"Bakker","year":"1991","journal-title":"Life Sci"},{"issue":"6","key":"10.1016\/j.nucmedbio.2007.05.002_bib22","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00259-003-1142-0","article-title":"Optimising conditions for radiolabelling of DOTA-peptides with 90Y, 111In and 177Lu at high specific activities","volume":"30","author":"Breeman","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"10.1016\/j.nucmedbio.2007.05.002_bib23","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1007\/s002590000296","article-title":"Cholecystokinin receptor imaging using an octapeptide DTPA-CCK analogue in patients with medullary thyroid carcinoma","volume":"27","author":"Kwekkeboom","year":"2000","journal-title":"Eur J Nucl Med"},{"issue":"5","key":"10.1016\/j.nucmedbio.2007.05.002_bib24","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s002590050247","article-title":"Unsulfated DTPA- and DOTA-CCK analogs as specific high-affinity ligands for CCK-B receptor-expressing human and rat tissues in vitro and in vivo","volume":"25","author":"Reubi","year":"1998","journal-title":"Eur J Nucl Med"},{"issue":"5","key":"10.1016\/j.nucmedbio.2007.05.002_bib25","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/(SICI)1097-0215(19991126)83:5<657::AID-IJC15>3.0.CO;2-Y","article-title":"Pre-clinical evaluation of [(111)In-DTPA-Pro(1), Tyr(4)]bombesin, a new radioligand for bombesin-receptor scintigraphy","volume":"83","author":"Breeman","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.nucmedbio.2007.05.002_bib26","doi-asserted-by":"crossref","DOI":"10.1007\/s00259-006-0356-3","article-title":"Novel (111)In-labelled bombesin analogues for molecular imaging of prostate tumours","author":"de Visser","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"10.1016\/j.nucmedbio.2007.05.002_bib27","first-page":"1012","article-title":"Use of polyglutamic acids to reduce uptake of radiometal-labeled minigastrin in the kidneys","volume":"46","author":"Behe","year":"2005","journal-title":"J Nucl Med"},{"issue":"3","key":"10.1016\/j.nucmedbio.2007.05.002_bib28","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0969-8051(02)00417-1","article-title":"Biodistribution of 111In-DTPA-d-Phe1-octreotide in tumor-bearing nude mice: influence of amount injected and route of administration","volume":"30","author":"Bernhardt","year":"2003","journal-title":"Nucl Med Biol"},{"issue":"2","key":"10.1016\/j.nucmedbio.2007.05.002_bib29","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/snuc\/2002.31025","article-title":"Phase I study of peptide receptor radionuclide therapy with [In-DTPA]octreotide: the Rotterdam experience","volume":"32","author":"Valkema","year":"2002","journal-title":"Semin Nucl Med"},{"issue":"Suppl. A","key":"10.1016\/j.nucmedbio.2007.05.002_bib30","first-page":"5","article-title":"Final conference COST action B12. Optimisation of In-111 labelled minigastrin related to the kidney uptake [Abstract]","volume":"8","author":"Behe","year":"2005","journal-title":"Nuclear Medicine Review"},{"issue":"11","key":"10.1016\/j.nucmedbio.2007.05.002_bib31","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1093\/ndt\/17.11.1867","article-title":"Megalin and cubilin \u2014 the story of two multipurpose receptors unfolds","volume":"17","author":"Verroust","year":"2002","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.nucmedbio.2007.05.002_bib32","first-page":"349","article-title":"Segmental distribution of the endocytosis receptor gp330 in renal proximal tubules","volume":"66","author":"Christensen","year":"1995","journal-title":"Eur J Cell Biol"},{"issue":"3","key":"10.1016\/j.nucmedbio.2007.05.002_bib33","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1523-1755.2005.00160.x","article-title":"Endocytosis of the somatostatin analogue, octreotide, by the proximal tubule-derived opossum kidney (OK) cell line","volume":"67","author":"Barone","year":"2005","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.nucmedbio.2007.05.002_bib34","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000092212","article-title":"Renal tubular drug transporters","volume":"103","author":"Launay-Vacher","year":"2006","journal-title":"Nephron Physiol"},{"issue":"4","key":"10.1016\/j.nucmedbio.2007.05.002_bib35","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2967\/jnumed.106.036020","article-title":"Indication for different mechanisms of kidney uptake of radiolabeled peptides","volume":"48","author":"Gotthardt","year":"2007","journal-title":"J Nucl Med"},{"issue":"Suppl 1","key":"10.1016\/j.nucmedbio.2007.05.002_bib36","first-page":"99S","article-title":"Patient-specific dosimetry in predicting renal toxicity with (90)Y-DOTATOC: relevance of kidney volume and dose rate in finding a dose\u2013effect relationship","volume":"46","author":"Barone","year":"2005","journal-title":"J Nucl Med"},{"issue":"10","key":"10.1016\/j.nucmedbio.2007.05.002_bib37","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1097\/00006231-200210000-00012","article-title":"Tissue distribution of octreotide binding receptors in normal mice and strains prone to autoimmunity","volume":"23","author":"Ten Bokum","year":"2002","journal-title":"Nucl Med Commun"},{"issue":"9","key":"10.1016\/j.nucmedbio.2007.05.002_bib38","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1210\/en.141.9.3304","article-title":"Preclinical comparison in AR4-2J tumor-bearing mice of four radiolabeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-somatostatin analogs for tumor diagnosis and internal radiotherapy","volume":"141","author":"Froidevaux","year":"2000","journal-title":"Endocrinology"},{"issue":"9","key":"10.1016\/j.nucmedbio.2007.05.002_bib39","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.peptides.2003.12.025","article-title":"Urinary proteins and the modulation of chemical scents in mice and rats","volume":"25","author":"Beynon","year":"2004","journal-title":"Peptides"},{"issue":"1\u20132","key":"10.1016\/j.nucmedbio.2007.05.002_bib40","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0167-4838(00)00149-7","article-title":"Major urinary proteins, alpha(2U)-globulins and aphrodisin","volume":"1482","author":"Cavaggioni","year":"2000","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"10.1016\/j.nucmedbio.2007.05.002_bib41","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00259-002-0982-3","article-title":"Safe and effective inhibition of renal uptake of radiolabelled octreotide by a combination of lysine and arginine","volume":"30","author":"Rolleman","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"31","key":"10.1016\/j.nucmedbio.2007.05.002_bib42","doi-asserted-by":"crossref","first-page":"29410","DOI":"10.1074\/jbc.M102916200","article-title":"Kidney androgen-regulated protein interacts with cyclophilin B and reduces cyclosporine A-mediated toxicity in proximal tubule cells","volume":"276","author":"Cebrian","year":"2001","journal-title":"J Biol Chem"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096980510700131X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096980510700131X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T22:26:47Z","timestamp":1546640807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096980510700131X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S096980510700131X"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2007.05.002","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}